AN INTEGRATED FORMAL FRAMEWORK FOR REIMBURSEMENT, RESEARCH AND PRICING DELIBERATIONS IN HEALTH TECHNOLOGY ASSESSMENT

被引：1
|
作者：
Griffin, S. [1 ]
Spackman, E. [2 ]
Soares, M. O. [1 ]
McKenna, C. [1 ]
Claxton, K. [1 ]
机构：
[1] Univ York, York YO10 5DD, N Yorkshire, England
[2] Univ York, Heslington, N Yorkshire, England
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1631
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A491 / A491
页数：1
相关论文
共 50 条
  • [1] Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
    Drummond, Michael
    Joensson, Bengt
    Rutten, Frans
    Stargardt, Tom
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2011, 12 (03): : 263 - 271
  • [2] PRICING, REIMBURSEMENT, AND HEALTH TECHNOLOGY ASSESSMENT OF MEDICINAL PRODUCTS IN BULGARIA
    Benisheva-Dimitrova, Tatyana
    Sidjimova, Dobriana
    Cherneva, Daniela
    Kralimarkov, Nikolay
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2017, 33 (03) : 365 - 370
  • [3] Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
    Michael Drummond
    Bengt Jönsson
    Frans Rutten
    Tom Stargardt
    [J]. The European Journal of Health Economics, 2011, 12 : 263 - 271
  • [4] Health technology assessment and its impact on pharmaceutical pricing and reimbursement policies
    Castillo-Labordo, Carla
    Silva-Illanes, Nicolas
    [J]. REVISTA MEDICA DE CHILE, 2014, 142 (01) : S33 - S38
  • [5] BARRIERS TO AND FACILITATORS OF THE APPLICATION OF HEALTH TECHNOLOGY ASSESSMENT IN MEDICINE PRICING AND REIMBURSEMENT POLICIES IN INDONESIA
    Wasir, R.
    Irawati, S.
    Makady, A.
    Postma, M. J.
    Goettsch, W.
    Feenstra, T.
    Buskens, E.
    [J]. VALUE IN HEALTH, 2018, 21 : S184 - S184
  • [6] Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies
    David Elvira
    Mercè Obach
    Caridad Pontes
    [J]. BMC Health Services Research, 21
  • [7] Capacity Building for Health Technology Assessment in Jordan: Institutionalization and Its Use in Pricing and Reimbursement Decisions
    Almomani, Emad
    Hammad, Eman A.
    AlQutob, Raeda
    Abu Hammour, Khawla
    Al-Sharu, Emad
    Abu-Shaer, Muien
    Alabbadi, Ibrahim
    Kalo, Zoltan
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2022, 32 : 47 - 53
  • [8] Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies
    Elvira, David
    Obach, Merce
    Pontes, Caridad
    [J]. BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
  • [9] PHARMACEUTICAL SYSTEM IN UKRAINE: IMPLEMENTATION OF EXTERNAL REFERENCE PRICING, REIMBURSEMENT PROGRAMS AND HEALTH TECHNOLOGY ASSESSMENT
    Piniazhko, O.
    Zaliska, O.
    Ilyk, R.
    Stasiv, Kh-O
    [J]. PHARMACIA, 2018, 65 (02) : 28 - 39
  • [10] Reimbursement of biosimilars in Poland: is there a link to health technology assessment?
    Neumann, Dominika
    Jablecka, Anna
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (06) : 781 - 792
12345